Von Willebrand factor (LFB)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVon Willebrand factor (LFB)
Drug Alias Name血管性血友病因子 (LFB)WillfactWilFactinWillefactvWF-SD-35-DH
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VIII stimulantsVon willebrand factor replacementsBlood coagulation pathway activation
TargetsCoagulation factor VIII
Therapy Area/Indicationsvon Willebrand Diseases
Global Approved Indicationsvon Willebrand Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date2003/09/30
Country/TerritoryFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLfb Biotechnologies Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active Indicationsvon Willebrand Diseases
Inactive IndicationsN/A

Other Information

ATC CodeB02BD10
Related LinksN/A